Early detection leads to early treatment.

Molecular Breast Imaging (MBI) is saving lives. MBI is a strong tool in early breast cancer detection and reveals cancerous lesions even in women with dense breasts and difficult-to-read mammograms. Factors such as breast density can limit the effectiveness of a mammogram.  MBI provides images that enable doctors to see the breast more clearly and can help verify if an area of concern is cancerous or not.

The Dilon Difference

Molecular Breast Imaging (MBI)  is an excellent problem-solving tool when faced with  difficult-to-diagnose patients.  MBI has been proven to identify disease in its earliest stages, often before it can be felt to the touch or seen with other imaging technologies such as Mammograms, Ultrasound, or MRI.  By finding cancers missed by other imaging techniques, it can lead to fewer benign biopsies than MRI, and improve surgical planning by detecting the position of the tumor.

Use the slider on the image to the right to see the Dilon Difference in action and compare a traditional mammogram with a Dilon Molecular Breast Image.

There is no doubt in my mind the MBI was the more effective means to finding my breast cancer. — Sandra, Hampton, VA

To me, this test is phenomenal. — Staci, Manalapan, NJ

With the MBI test I was able to get results the same day and leave the doctor’s office with an answer. — Shelly, Washington, DC

Dilon Partners